NFKB1 and Parkinson disease: Spermidine pretreatment reduced M1 microglial polarization and promoted M2 microglial polarization by inhibiting the NF‐κB/STAT1 signaling pathways, thereby alleviating neuroinflammation in both the MPTP mouse model of Parkinson's disease and LPS‐stimulated BV2 cells.